Synapse - Nursing

Results (3755)

Prospective FDG-PET and CT assessment of discontinuation of erlotinib (E) or gefitinib (G) in patients with EGFR TKI sensitive non-small cell lung cancer (NSCLC) who subsequently progress radiographically on E or G ("acquired resistance") followed by re-initiation of E or G and the subsequent addition of everolimus (RAD001)

Meeting Abstract

Riely, G. J.; Kris, M. G.; Schwartz, L. H.; Akhurst, T.; Zhao, B.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Miller, V. A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Infectious disease associations in advanced stage, indolent lymphoma (Follicular, FL and non-follicular, nFL): Developing a lymphoma prevention strategy

Meeting Abstract

Portlock, C. S.; Hamlin, P. A.; Noy, A.; Palomba, M. L.; Rosenzweig, L.; Walker, D.; Corcoran, S.; Chey, W. D.; Gaydos, C. A.; Schwartz, I.; more...
Blood (2006)

Fulltext@MSK | Save

Existential issues in pain and palliative care: A monthly lecture series for palliative care clinical fellows

Meeting Abstract

Poppito, S. R.; Coyle, N.; Obbens, E.
Psycho-Oncology (2006)

Fulltext@MSK | Save

Tobacco prevention and teens

Meeting Abstract

Plastini Mertens, K.
Oncology Nursing Forum (2006)

Fulltext@MSK | Save

Implementation of venous thromboembolism prophylaxis guidelines on a GYN oncology in-patient nursing unit

Meeting Abstract

Osoria, J.; Dulko, D.; Vasquez-Clarfield, B.
Oncology Nursing Forum (2006)

Fulltext@MSK | Save

Implementation of a primary nursing model to optimize patient care and safety in an outpatient chemotherapy unit

Meeting Abstract

Olstrom, J.; Albanese, P.
Oncology Nursing Forum (2006)

Fulltext@MSK | Save

Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience

Meeting Abstract

O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; more...
Blood (2006)

Fulltext@MSK | Save

ZD6474 versus gefitinib in patients with advanced NSCLC: Final results from a two-part, double-blind, randomized phase II trial

Meeting Abstract

Natale, R. B.; Bodkin, D.; Govindan, R.; Sleckman, B.; Rizvi, N.; Capo, A.; Germonpre, P.; Stockman, P.; Kennedy, S.; Ranson, M.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

A phase II trial of stereotactic radiosurgery boost following surgical resection for solitary brain metastases

Meeting Abstract

Narayana, A.; Chan, K.; Brennan, C.; Chang, J.; Higgins, V.; Lymberis, S.; Yamada, J.; Gutin, P. H.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease

Meeting Abstract

Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save